Literature DB >> 17514626

Comparison of lipid measures and risk stratification among end-stage renal disease patients.

Rodney G Bowden1, Stuart Hebert, Ronald Wilson, Mindy Gentile, Beth A Lanning.   

Abstract

BACKGROUND: Abnormal lipid profiles are associated with end-stage renal disease (ESRD) which significantly contributes to an accelerated progression of coronary artery disease. The purpose of this study was to examine the relationships between cholesterol measures and differences in risk stratification when using National Cholesterol Education Program, Adult Treatment Panel, Third Report (ATP-III) guidelines, compared with cholesterol particle number and size in ESRD patients.
METHODS: Lipid profiles were conducted on 541 ESRD patients who were chronic hemodialysis patients. Lipid profiles were measured using gel electrophoresis and their particle size and concentration measured using nuclear magnetic resonance (NMR) spectroscopy. Correlations and risk stratification were compared between each lipid measure.
RESULTS: The findings suggest that low-density lipoprotein (LDL) size does not correlate well with LDL cholesterol and LDL particle number. The findings also suggest a "disconnect" between traditional lipid measures and cholesterol concentration and size when using ATP-III guidelines for risk stratification.
CONCLUSIONS: The cholesterol risk designation variances between risk stratification guidelines and the relationships established through Pearson correlations, as illustrated within this patient pool, reveal the complex differences between measures of coronary artery disease risk. These additional patients considered at-risk using NMR technology may help to identify more patients at need for intervention and treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514626

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Lipoprotein subfractions and particle size in end-stage renal disease.

Authors:  Peter A McCullough; Fawaz Al-Ejel; Robert C Maynard
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

2.  LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.

Authors:  Rodney G Bowden; Ronald L Wilson; A Alexander Beaujean
Journal:  J Nephrol       Date:  2011 Nov-Dec       Impact factor: 3.902

3.  The Effects of Lowering Uric Acid Levels Using Allopurinol on Components of Metabolic Syndrome.

Authors:  Esther J Heimbach; Rodney G Bowden; Jackson O Griggs; A Alexander Beaujean; Eva I Doyle; Robert D Doyle
Journal:  Cardiol Res       Date:  2012-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.